The purpose of this pack is to provide guidance documentation for people involved in the process of Clinical and Technical Assurance (C&TA) of Medicines.
The audiences of this documentation are internal NHS Digital programmes, external stakeholders and implementation sites using FHIR specifications. It is assumed that the reader has a basic understanding of HL7 FHIR.
This pack contains the guidance and reference material required to participate in the Sprint 4 of C&TA. The content of the UK Core to be reviewed is contained in the HL7 FHIR® UK Core Profiles for R4 (Draft Standard for Trial Use). Items are indexed by C&TA Sprints and the scope of this sprint is items marked Sprint 4.
This documentation is released as Sprint 4 of the FHIR clinical and technical assurance process. This sprint involves creating a review pack for external consultation, including a first draft of mapping by a core team which is published to the external community for a review period of 15 working days. This process is documented and is available in Simplifier. This C&TA process is a replacement for the curation process used for the FHIR STU3 CareConnect profiles. The documentation will give background information to allow the reader to take part in the C&TA process.
If you require more training on HL7 FHIR, please watch the videos in Training.